Article
A network‐based predictive gene expression signature for recurrence risks in stage II colorectal cancer
14 Nov 2019
Abstract excerpt
The current criteria for defining the recurrence risks of stage II colorectal cancer (CRC) are not robust; therefore, we aimed to explore novel gene signatures to predict recurrence risks and to reveal the underlying mechanisms of stage II CRC. First, the gene expression profiles of 124 patients with stage II CRC from The Cancer Genome Atlas (TCGA) database were obtained to screen differentially expressed genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
